NCT00684489 |
Completed |
Hypertension |
52 |
Hydralazine and other drugs |
NCT02305095 |
Not open for participant recruitment |
Heart failure |
500 (estimated enrollment) |
Hydralazine in combination with isosorbide dinitrate |
NCT00661895 |
Completed |
Hypertension |
99 |
Hydralazine and other drugs |
NCT00599235 |
Completed |
Hypertension |
30 |
Hydralazine, sildenafil, and placebo |
NCT00223717 |
Recruiting participants |
Hypertension |
160 (estimated enrollment) |
Hydralazine and other drugs |
NCT01255475 |
Completed |
Heart failure, cardiac failure, and congestive heart failure |
21 |
Hydralazine/amlodipine and placebo |
NCT01516346 |
Recruiting participants |
Heart failure and congestive heart failure |
54 (estimated enrollment) |
Hydralazine, isosorbide dinitrate, and placebo |
NCT01822808 |
Recruiting participants |
Acute heart failure and left ventricular dysfunction |
500 (estimated enrollment) |
Hydralazine, isosorbide dinitrate, and placebo |
NCT00000499 |
Completed |
Cardiovascular diseases, heart diseases, hypertension, and vascular diseases |
Not provided |
Hydralazine, reserpine, chlorthalidone, and metoprolol |
NCT02050529 |
Recruiting participants |
Hypertension, Pregnancy induced |
180 (estimated enrollment) |
Hydralazine, labetalol |
NCT01538875 |
Completed |
Hypertension, Pregnancy induced |
261 |
Hydralazine, labetalol |
NCT00383799 |
Unknown |
Ventricular tachycardia |
302 (estimated enrollment) |
Procainamide, amiodarone |
NCT00000464 |
Completed |
Arrhythmia, Cardiovascular diseases |
115 |
Procainamide, quinidine, disopyramide, and other drugs |
NCT00702117 |
Completed |
Atrial fibrillation, tachycardia |
123 |
Procainamide, ajmaline, flecainide |
NCT00589303 |
Terminated |
Atrial fibrillation, heart failure |
27 |
Rhythm control drugs: Procainamide and other drugs |
NCT00000556 |
Completed |
Arrhythmia, atrial fibrillation, cardiovascular diseases |
4060 |
Procainamide and other drugs |
NCT01205529 |
Recruiting |
Atrial fibrillation |
750 (estimated enrollment) |
Procainamide |